GeneDx Holdings Corp. (WGS)
NASDAQ · Healthcare
GeneDx Holdings Corp. annual/quarterly shareholder equity history from 2020 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- GeneDx Holdings Corp. shareholder equity for the quarter ending December 31, 2025 were 308.2M, a 25.66% increase year-over-year.
- GeneDx Holdings Corp. shareholder equity for 2025 were 308.2M, a 25.66% increase from 2024.
- GeneDx Holdings Corp. shareholder equity for 2024 were 245.2M, a 7.56% increase from 2023.
- GeneDx Holdings Corp. shareholder equity for 2023 were 228.0M, a 10.13% decrease from 2022.
- GeneDx Holdings Corp. shareholder equity for 2022 were 253.7M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| GeneDx Holdings Corp. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $308 |
| 2024 | $245 |
| 2023 | $228 |
| 2022 | $254 |
| 2021 | $388 |
| 2020 | $-330 |
| GeneDx Holdings Corp. Quarterly Shareholder Equity (Millions of US $) | |
|---|---|
| 2025-12-31 | $308 |
| 2024-12-31 | $245 |
| 2023-12-31 | $228 |
| 2022-12-31 | $254 |
| 2021-12-31 | $388 |
| 2020-12-31 | $-330 |
GeneDx Holdings Corp. Shareholder Equity — FAQ
GeneDx Holdings Corp. (WGS) shareholder equity over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see WGS's shareholder equity history?
The chart and table above show GeneDx Holdings Corp.'s shareholder equity by year and by quarter, including the growth rate.